News & Events

Keep upto date with all the latest news and insights from Nanopharm.

  • Nanopharm & Leyden Labs announce agreement

    Read the full press release

    Read More
  • Nanopharm Ltd acquired by AptarGroup

    Read the full press release

    Read More
  • Join us at InspireMe in San Francisco, June 4-5, 2019.

    InspireMe promises to be the DPI and Soft Mist industry event of the year.

    Read More
  • Meet disruptive innovation at RDD Europe 2019

    Nanopharm is creating value for our clients through disruptive innovation in respiratory product development.

    Read More
  • Nanopharm Limited & Sciarra Laboratories Inc

    Announce Strategic Alliance

    Read More
  • Nanopharm Announce Appointment of Head of Device Development

    Device Development Established at Nanopharm Ltd

    Read More
  • Nanopharm Announces Appointment of Chairman

    Nanopharm Announces the Appointment of Mark Clement as Chairman of the Board

    Read More
  • Addition of the Malvern G3-ID at Nanopharm

    Demonstrating bioequivalence (BE) for complex generics such as nasal spray suspension drug products is a challenging task. Sponsors not only have to consider device requirements but also understand the properties of the API in the presence of functional excipients.

    Read More